Original Research

A budget impact analysis of Spiromax® compared with Turbuhaler® for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions

Darbà J, Ramírez G, García-Rivero JL, Mayoralas-Alises S, Pascual JF, Roger A,Vargas D, Bijedic A

ClinicoEconomics and Outcomes Research 2016, 8:435-444

Published Date: 6 September 2016